Preferred Label : Triple-Class Refractory Multiple Myeloma;

NCIt synonyms : Triple-Class Refractory Plasma Cell Myeloma;

NCIt definition : Multiple myeloma that is resistant to three classes of therapeutic agents, including proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies.;

Neoplastic status : Malignant;

NCI Metathesaurus CUI : CL1647794;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3303102/fr/abecma-idecabtagene-vicleucel-myelome-multiple
https://has-sante.fr/jcms/p_3303143/fr/decision-n-2021-0311/dc/sem-du-2-decembre-2021-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-abecma-idecabtagene-vicleucel
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
Idecabtagene Vicleucel
Idecabtagene Vicleucel
Receptors, Chimeric Antigen
immunotherapy, adoptive
adult
recurrence
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
infusions, intravenous
Triple-Class Refractory Multiple Myeloma
idecabtagene vicleucel
idecabtagene vicleucel
evaluation of the transparency committee
multiple myeloma

---
Nous contacter.
01/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.